TOP STORIES

• REGULATORY Health Minister Laments Drug Lag/Loss, Stresses Need for Govt-Driven Innovation Ecosystem
  October 16, 2023

• REGULATORY MHLW Regulatory Panel OKs New Procedures for Post-Approval Manufacturing Changes
  October 16, 2023

• BUSINESS Shonan iPark Looks to Woo Korean Firms by Partnering with Govt: Chief
  October 13, 2023

• ORGANIZATION Chuikyo Rep Interview 2-3 - With 80% Generic Share, Now Is the Time to Revisit LLP Copay, Says Payer Rep
  October 13, 2023

• REGULATORY MHLW Panel Proposes Assessing Generic Makers’ Efforts toward Stable Supplies, Reflecting Results in Pricing
  October 12, 2023

• REGULATORY Vyvgart, Dysval Braced for Price Cuts after CEA, No Change for Ondexxya
  October 12, 2023

• ACADEMIA G1 Product Info Could Disappear after Withdrawal, PMDA Website Should Retain Posting: Pharmacist
  October 11, 2023

• ORGANIZATION Chuikyo Rep Interview 2-2 - Payer Says Drug Prices Not Only Cause of Lag/Loss, Industry Proposal Needs More Details
  October 11, 2023

• ORGANIZATION Chuikyo Rep Interview 2-1 - As Japan Sees More Pricey Meds, Kenporen Director Wants Rethink of Health Coverage
  October 10, 2023

• ORGANIZATION Global CEOs Want Positive Sign from Japan, Sentiments Drive Decisions: EFPIA Chief
  October 6, 2023

• REGULATORY Post-Launch Re-Pricing Likely the Focus of Chuikyo Leqembi Discussions
  October 5, 2023

• ORGANIZATION Chuikyo Rep Interview 1 - JPA Vice President Warns against Rushed Dabate on Yakkasa, 2% Buffer Zone
  October 4, 2023

• BUSINESS Drug Makers Discontinue Sales of Alesion Dry Syrup, Generic Versions
  October 3, 2023

• REGULATORY As Copay Debate Picks Up Steam, MHLW Floats 4 Ideas for Coverage Reform
  October 2, 2023

• REGULATORY Japan Seeking Solutions as Lab Monkey Shortage, Price Surge Threaten to Stymie Drug Development
  October 2, 2023

• REGULATORY Guidelines Should Urge Drug Makers to Explain Solo-Wholesaler Decisions: Panel Members
  September 29, 2023

• REGULATORY As Chuikyo Begins Pricing Debate of Leqembi, Panelists Urge Safety, Fair Access
  September 28, 2023

• REGULATORY Japan Agrees to Buy Extra 10 Million Doses of Pfizer COVID Vaccine
  September 27, 2023

• BUSINESS Regeneron to Make Japan Debut with Dupixent Copromotion
  September 27, 2023

• REGULATORY Leqembi Subject to Cost Control Rule for Potential Big Sellers, MHLW Still Set to Meet Listing Deadline
  September 26, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 46
• 47
• 48
• 49
• 50
• 51
• 52
• 53
• 54
• …
• Next ›
• 最終 »